Full-Time

Simulation Realism Engineer

OpenAI

OpenAI

5,001-10,000 employees

Develops safe AI models and tools

Compensation Overview

$293k - $385k/yr

San Francisco, CA, USA

Hybrid

Relocation assistance provided; hybrid with 4 days on-site per week.

Category
Software Engineering (1)
Responsibilities
  • Define and operationalize realism metrics & protocols. Design experiments and automated tests to find specific areas of non-realism, quantify gaps, and track regressions over time.
  • Fine-tune engine parameters (contacts, friction, mass/density, solver settings) and object models so simulated dynamics match measured reality.
  • Evaluate, integrate, and — where necessary — extend 3rd-party physics, rendering, and sensor simulation engines (e.g., Isaac, PhysX, MuJoCo, video renderers or sensor sim frameworks). Lead vendor POCs and benchmark features to influence roadmaps.
  • Create standards, guidelines, and interactive tools for authoring and validating asset physical/visual properties; implement semi- or fully-automated pipelines to tune and optimize assets for target engines.
  • Solve technical issues for running engines in the cloud (OS, drivers, GPU), parallelize simulations (batching many runs per engine instance), and harden real-world-facing pipelines so sims can run reliably at scale.
  • Own validation campaigns (teleop, HIL regression suites, metric computation) and partner with research to close the loop between simulation improvements and downstream model performance.
  • Document and scale best practices. Produce ergonomic templates, docs, and standards so dozens of engineers and researchers can author realistic tasks and assets quickly.
Desired Qualifications
  • Have a strong mathematical & physics background — rigid/soft-body dynamics, contact mechanics, or FEA — and are comfortable reasoning about solvers and numerical stability.
  • Hands-on experience with at least one or two production physics engines and sensor/render stacks (MuJoCo, PhysX, Isaac Sim, Newton, GPU renderers, or equivalent), and know how to measure/interpret their failure modes.
  • Enjoy plumbing every layer of the sim stack: CAD/asset import, collision/visual mesh tradeoffs, contact tuning, real-time loading, and rendering pipelines.
  • Have led projects that bridge sim and robotics, such as teleoperation data collection, hardware-in-the-loop regression tests, or digital twin efforts.
  • Experienced building robust tools and processes — continuous integration for simulations, asset validation pipelines, or distributed GPU workloads — and care about documentation and ergonomics that let others be productive.
  • Can collaborate broadly: you want to work directly with researchers to design experiments, with software engineers to ship tooling, and with vendors to run benchmarks and influence product roadmaps.

OpenAI conducts AI research and deployment to build advanced AI models and tools that help people automate tasks, be more creative, and make better decisions. Its products include ChatGPT, a conversational AI that can write, code, tutor, and assist in interactive tasks, and Sora, which can generate videos from text prompts. OpenAI’s models typically run through cloud-based services and subscriptions, with licensing and partnerships for broader use. The company operates a capped-profit model to balance generating revenue with ensuring safety, ethics, and long-term societal benefits. Its approach emphasizes safety, responsible deployment, and collaboration with researchers, governments, and institutions. The goal is to ensure artificial general intelligence, when it arrives, benefits all of humanity and minimizes risks.

Company Size

5,001-10,000

Company Stage

Late Stage VC

Total Funding

$196B

Headquarters

San Francisco, California

Founded

2015

Simplify Jobs

Simplify's Take

What believers are saying

  • SoftBank pledges $30B more in 2026, valuing OpenAI at $850B with $25B annualized revenue.
  • University of Michigan's $20M investment yields $2B, signaling strong early investor returns.
  • TPG joint venture with billions in PE funding boosts corporate AI adoption rates.

What critics are saying

  • Microsoft divests after $100B spend by June 2026, funding Anthropic and xAI instead.
  • Doubled GPT-5.5 API prices to $5/$30 per million tokens slash 5% subscriber conversions.
  • Europe bans GPT-5.5-Cyber for non-partners post-Mythos, blocking Trusted Access expansion.

What makes OpenAI unique

  • Trusted Access for Cyber grants vetted users GPT-5.4-Cyber for binary reverse engineering.
  • Daybreak platform automates threat prioritization, patching, and fix verification in software development.
  • Deployment Company with 150 Tomoro engineers accelerates enterprise AI integration via partnerships.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at OpenAI who can refer or advise you

Benefits

Health insurance

Dental and vision insurance

Flexible spending account for healthcare and dependent care

Mental healthcare service

Fertility treatment coverage

401(k) with generous matching

20-week paid parental leave

Life insurance (complimentary)

AD&D insurance (complimentary)

Short-term/long-term disability insurance (complimentary)

Optional buy-up life insurance

Flexible work hours and unlimited paid time off (we encourage 4+ weeks per year)

Annual learning & development stipend

Regular team happy hours and outings

Daily catered lunch and dinner

Travel to domestic conferences

Growth & Insights and Company News

Headcount

6 month growth

-2%

1 year growth

3%

2 year growth

2%
Daring Fireball
May 8th, 2026
Y Combinator’s Stake in OpenAI

The fact that Paul Graham personally has billions of dollars at stake with OpenAI doesn’t mean that his public opinion on Sam Altman’s trustworthiness and leadership is invalid. But it certainly seems like the sort of thing that ought to be disclosed when quoting Graham as an Altman character reference.

Bloomberg L.P.
Apr 21st, 2026
OpenAI launches ChatGPT Images 2.0 with improved chart and diagram creation

OpenAI is releasing ChatGPT Images 2.0, an updated AI image-generating software designed to create accurate charts and scientific diagrams. The company aims to make its technology more appealing to professionals. Rolling out Tuesday through ChatGPT and Codex AI coding assistant, the new model improves instruction-following and detail incorporation when generating images. It can produce visuals across multiple styles and render text in various languages. The update represents OpenAI's effort to expand its AI capabilities beyond general use cases into professional applications requiring technical precision and accuracy.

Bloomberg L.P.
Apr 17th, 2026
OpenAI loses head of science initiatives and Sora AI video team leader

OpenAI's head of science initiatives and the leader of its Sora AI video team are leaving the company, adding to recent executive departures as the firm reorganises its product portfolio. The exits continue a pattern of senior leadership changes at the artificial intelligence company.

Bloomberg L.P.
Apr 16th, 2026
OpenAI unveils GPT-5.4 to tackle enterprise trust and governance concerns

OpenAI is addressing enterprise adoption challenges with GPT-5.4 "Cyber", focusing on security, trust and governance issues. Erica Brescia, managing director at Redpoint Ventures and OpenAI backer, discussed the development, emphasising that the AI cyber race centres on governance rather than purely technological advancement. The move represents OpenAI's effort to overcome barriers preventing widespread enterprise adoption of its AI systems by prioritising security features in its latest model release.

Bloomberg L.P.
Apr 16th, 2026
OpenAI launches GPT-Rosalind AI model for drug discovery to rival Google

OpenAI has launched GPT-Rosalind, an AI model designed to accelerate drug discovery and life sciences research. The model aims to extract insights from large datasets and help translate scientific studies into healthcare applications. Initially available as a research preview to select business customers, GPT-Rosalind's early users include pharmaceutical company Amgen, vaccine maker Moderna and bioscience research nonprofit the Allen Institute. The launch positions OpenAI alongside other technology companies entering the drug discovery field, as the industry seeks to demonstrate AI's potential for scientific breakthroughs. The ChatGPT maker announced the model's release on Thursday.